Voisins le Bretonneaux, France

Mathieu Rafaël Pizzonero

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 15.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Voisins le Bretonneux, FR (2017 - 2018)
  • Romainville, FR (2014 - 2021)
  • Voisins le Bretonneaux, FR (2020 - 2021)

Company Filing History:


Years Active: 2014-2021

where 'Filed Patents' based on already Granted Patents

9 patents (USPTO):

Title: Innovations of Mathieu Rafaël Pizzonero

Introduction

Mathieu Rafaël Pizzonero is a notable inventor based in Voisins le Bretonneux, France. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of cystic fibrosis. With a total of nine patents to his name, Pizzonero's work has the potential to impact many lives.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use." This invention discloses compounds of Formula (I), wherein A, R, R, R, R, and n are defined. The present invention relates to these compounds and their use in treating cystic fibrosis, including methods for their production, pharmaceutical compositions, and treatment methods involving the administration of these compounds.

Career Highlights

Pizzonero has worked with prominent companies in the pharmaceutical industry, including Galapagos NV and AbbVie Overseas S.à.r.l. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Some of his notable coworkers include Nicolas Desroy and Gregory A. Gfesser. Their collaboration has likely fostered an environment of creativity and innovation, leading to the development of impactful inventions.

Conclusion

Mathieu Rafaël Pizzonero's contributions to the field of cystic fibrosis treatment through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…